Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 38.40
+0.10 (0.26%)
At close: Mar 6, 2026
Dermapharm Holding SE Market Cap
Dermapharm Holding SE has a market cap or net worth of €2.07 billion as of March 6, 2026. Its market cap has decreased by -2.41% in one year.
Market Cap
2.07B
Enterprise Value
2.93B
Revenue
1.17B
Ranking
n/a
PE Ratio
17.83
Stock Price
€38.40
Market Cap Chart
Since February 9, 2018, Dermapharm Holding SE's market cap has increased from 1.40B to 2.07B, an increase of 47.69%. That is a compound annual growth rate of 4.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.07B | -2.41% |
| Dec 30, 2025 | 2.12B | 1.16% |
| Dec 30, 2024 | 2.09B | -8.12% |
| Dec 29, 2023 | 2.28B | 12.85% |
| Dec 30, 2022 | 2.02B | -57.98% |
| Dec 30, 2021 | 4.81B | 56.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 47.89B |
| Siemens Healthineers AG | 45.09B |
| Bayer Aktiengesellschaft | 35.75B |
| Fresenius SE & Co. KGaA | 26.32B |
| Ottobock SE & Co. KGaA | 3.69B |
| Fielmann Group AG | 3.67B |
| Carl Zeiss Meditec AG | 2.19B |
| SCHOTT Pharma AG & Co. KGaA | 2.11B |